NAPA
Alpha-soluble NSF attachment protein
Also known as: SNAA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P54920
- Gene
- NAPA
- Ensembl
- ENSG00000105402
- Chromosome
- 19
- Canonical length
- 295 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the soluble NSF attachment protein (SNAP) family. SNAP proteins play a critical role in the docking and fusion of vesicles to target membranes as part of the 20S NSF-SNAP-SNARE complex. The encoded protein plays a role in the completion of membrane fusion by mediating the interaction of N-ethylmaleimide-sensitive factor (NSF) with the vesicle-associated and membrane-associated SNAP receptor (SNARE) complex, and stimulating the ATPase activity of NSF. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
295 residues, UniProt reviewed canonical sequence.
>P54920|NAPA
1 MDNSGKEAEA MALLAEAERK VKNSQSFFSG LFGGSSKIEE ACEIYARAAN MFKMAKNWSA
61 AGNAFCQAAQ LHLQLQSKHD AATCFVDAGN AFKKADPQEA INCLMRAIEI YTDMGRFTIA
121 AKHHISIAEI YETELVDIEK AIAHYEQSAD YYKGEESNSS ANKCLLKVAG YAALLEQYQK
181 AIDIYEQVGT NAMDSPLLKY SAKDYFFKAA LCHFCIDMLN AKLAVQKYEE LFPAFSDSRE
241 CKLMKKLLEA HEEQNVDSYT ESVKEYDSIS RLDQWLTTML LRIKKTIQGD EEDLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAPA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 209 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 209 nTPM
- skeletal muscle: 195 nTPM
- liver: 176 nTPM
- cerebral cortex: 175 nTPM
- adrenal gland: 163 nTPM
- skin: 145 nTPM
Single-cell type
- neutrophils: 180 nCPM
- cone photoreceptor cells: 141 nCPM
- colonocytes: 137 nCPM
- enterocytes: 133 nCPM
- esophageal apical cells: 132 nCPM
- neuroendocrine cells: 111 nCPM
Immune cell
- eosinophil: 314 nTPM
- plasmacytoid DC: 210 nTPM
- total PBMC: 209 nTPM
- non-classical monocyte: 202 nTPM
- basophil: 197 nTPM
- intermediate monocyte: 190 nTPM
Brain region
- cerebral cortex: 207 nTPM
- hippocampal formation: 166 nTPM
- pons: 157 nTPM
- cerebellum: 137 nTPM
- thalamus: 137 nTPM
- white matter: 137 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.24
- gnomAD missense Z
- 0.99
- DepMap mean gene effect
- -1.35
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apical protein localization
- brain development
- intra-Golgi vesicle-mediated transport
- intracellular protein transport
- membrane fusion
- neuron differentiation
- regulation of synaptic vesicle priming
- SNARE complex disassembly
- synaptic transmission, glutamatergic
- synaptic vesicle priming
Molecular functions
- protein-containing complex binding
- SNARE binding
- soluble NSF attachment protein activity
- syntaxin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAPA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAPA as an antibody target. Whether an autoantibody or antibody against NAPA could matter depends on whether native NAPA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAPA is annotated at the cell surface, where native NAPA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NAPA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...